EcoDrugPlus

Ensembl ID : ENSODEG00000018554
Gene Symbol: -
Cross references: -
288 Possible Orthologues:

Ensembl ID : ENSODEG00000018607
Gene Symbol: -
Cross references: -
161 Possible Orthologues:

Ensembl ID : ENSODEG00000019271
Gene Symbol: -
Cross references: -
288 Possible Orthologues:

Ensembl ID : ENSODEG00000019365
Gene Symbol: -
Cross references: -
288 Possible Orthologues:

Ensembl ID : ENSODEG00000019396
Gene Symbol: -
Cross references: -
68 Possible Orthologues:

Ensembl ID : ENSODEG00000019466
Gene Symbol: -
Cross references: -
153 Possible Orthologues:

Ensembl ID : ENSODEG00000019715
Gene Symbol: -
Cross references: -
231 Possible Orthologues:

Ensembl ID : ENSODEG00000019864
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSODEG00000020381
Gene Symbol: -
Cross references: -
48 Possible Orthologues:

Ensembl ID : ENSODEG00000005022
Gene Symbol: -
Cross references: -
140 Possible Orthologues:

Ensembl ID : ENSODEG00000005134
Gene Symbol: -
Cross references: -
239 Possible Orthologues:

Ensembl ID : ENSODEG00000005047
Gene Symbol: -
Cross references: -
245 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).